<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        19-163-04
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2004
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        OCTAPLAS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PLASMA PROTEIN FRACTION
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        9.0 - 14.0
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        g
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        200
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bag
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        519.1
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="OCTAPHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            OCTAPHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 521]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Faisal Musaed El Seif Saudi Pharmaceutical Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            OCTAPHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05AA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
            <div class="p-20 text-center font-20">
                <div class="p-10 bg-red"><i class="fa fa-times-circle"></i>&nbsp;&#x644;&#x645; &#x64A;&#x62A;&#x645; &#x625;&#x62F;&#x62E;&#x627;&#x644; &#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A;  &#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x644;&#x647;&#x630;&#x627; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621; &#x62D;&#x62A;&#x649; &#x627;&#x644;&#x622;&#x646;</div>
            </div>
    </div>
    <div id="A-div" class="box-data">
            <div class="p-20 text-center font-20">
                <span class="p-10 bg-red"><i class="fa fa-times-circle"></i>&nbsp;&#x644;&#x645; &#x64A;&#x62A;&#x645; &#x625;&#x62F;&#x62E;&#x627;&#x644; &#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A;  &#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x644;&#x647;&#x630;&#x627; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621; &#x62D;&#x62A;&#x649; &#x627;&#x644;&#x622;&#x646;</span>
            </div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                OCTAPLAS, solution for infusion
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Octaplas is presented as an ABO-blood group specific solution for infusion containing 45 – 70 mg human
plasma proteins/mL.
For details about important coagulation factors and inhibitors, see section 5.1 and Table 2.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for infusion
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>- Complex deficiencies of coagulation factors such as coagulopathy due to severe hepatic failure or massive transfusion.<br />- Substitution therapy in coagulation factor deficiencies, when a specific coagulation factor concentrate (e.g. factor V<br />or factor XI) is not available for use or in emergency situations when a precise laboratory diagnosis is not possible.<br />- Rapid reversal of the effects of oral anticoagulants (coumarin or indanedione type), when a prothrombin complex<br />concentrate is not available for use or administration of vitamin K is insufficient due to impaired liver function or in<br />emergency situations.<br />- Potentially dangerous haemorrhages during fibrinolytic therapy, using e.g. tissue plasminogen activators, in patients<br />who fail to respond to conventional measures.<br />- Therapeutic plasma exchange procedures, including those in thrombotic thrombocytopenic purpura (TTP).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Posology:</strong><br />The dosage depends on the clinical and personal condition and underlying disorders. However, 12 to 15 mL Octaplas/kg<br />body weight (to increase the patient&rsquo;s plasma coagulation factor levels by approximately 25 %) is a generally accepted<br />starting dose. . It is important to monitor the response, both clinically and through the measurement of prothrombin time<br />(PT), partial thromboplastin time (PTT), and/or the dosage of specific coagulation factors.<br />Dosage for coagulation factor deficiencies:<br />An adequate haemostatic effect in minor and moderate haemorrhages or surgery in coagulation factor deficient patients<br />is normally achieved after the infusion of 5-20 mL Octaplas/kg body weight. This should increase the patient&rsquo;s plasma<br />coagulation factor levels by approximately 10-33 %.<br />In the case of severe haemorrhage or major surgery the advice of an expert in haematology should be sought.<br />Dosage for TTP and haemorrhage in intensive plasmapheresis procedures:<br />In patients with TTP the entire plasma volume should be replaced with Octaplas.<br />In case of severe haemorrhage during intensive plasmapheresis procedures, the advice of an expert in haematology<br />should be sought.<br /><u>Method of administration:</u><br />Administration of Octaplas must be based on ABO-blood group specificity. In emergency cases, Octaplas blood group AB<br />may be considered as universal plasma, since it may be given to all patients.<br />Octaplas must be administered by intravenous infusion after thawing, as described in section 6.6, using an infusion set with<br />a filter. An aseptic technique must be used throughout the infusion.<br />Due to the risk of citrate toxicity, the infusion rate should not exceed 0.020-0.025 mmol citrate/kg body weight/minute<br />- equal to &le;1 mL Octaplas/kg body weight/minute. Toxic effects of citrate can be minimised by giving calcium gluconate<br />intravenously into another vein.<br /><u>Paediatric population</u><br />The efficacy and safety of Octaplas have not been evaluated in pediatric patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                - IgA deficiency with documented antibodies against IgA.
- Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 or residues from the
manufacturing process, as stated in section 5.3.
- Severe deficiencies of protein S
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Octaplas must be used with caution under the following conditions:</strong><br />- IgA deficiency.<br />- Plasma protein allergy.<br />- Previous reactions to fresh-frozen plasma (FFP) or Octaplas.<br />- Manifest or latent cardiac decompensation.<br />- Pulmonary oedema.<br />OCTAPLAS must be used with caution in patients that have a risk of thrombotic complications due to a potential increased<br />risk of venous thromboembolism resulting from a reduced protein S activity of OCTAPLAS compared to fresh frozen plasma<br />from a single donor.<br />OCTAPLAS must not be used as a plasma volume expander in patients without documented coagulation factor deficiencies.<br />OCTAPLAS must not be used in case of haemorrhage caused by von Willebrand Disease (vWD) or other coagulation factor<br />deficiencies when concentrates of the specific factors are available.<br />OCTAPLAS must not be used to correct hyperfibrinolysis caused by a deficiency of the plasmin inhibitor, alpha2-antiplasmin,<br />since dilution with S/D treated plasma (which contains low levels of alpha2-antiplasmin) could then reduce the levels of<br />alpha2-antiplasmin.<br />Special attention must be given to, Monitor for signs of excessive bleeding in patients who might require massive<br />transfusion, such as, for example those undergoing liver transplantation or in other conditions with complex homoeostasis<br />disorders.</p><p>In intensive plasma exchange procedures, Octaplas should only be used to correct the coagulation abnormality when<br />abnormal haemorrhage occurs.<br /><strong>Viral Safety</strong><br />Standard measures to prevent infections resulting from the use of medical products prepared from human blood or plasma<br />include selection of donors, screening of individual donations and plasma pool for specific markers of infection and the<br />inclusion of effective manufacturing steps for the inactivation/removal of viruses. Despite this, when medicinal products<br />prepared from human blood or plasma are administered, the possibility of transmitting infective agents cannot be totally<br />excluded. This also applies to unknown and emerging viruses and other pathogens.<br />A maximum of 1520 single donations are used for the manufacture of Octaplas.<br />The safety measures (including S/D treatment) taken are considered effective for enveloped viruses e.g. HIV, HBV, and HCV.<br />The measures taken may be of limited value against non-enveloped viruses such as HAV, HEV and Parvovirus B19. However,<br />the risk of transmission of infective agents is reduced by the testing of each plasma pool for genomic material. Only plasma<br />pools that are negative in all applicable serological tests as well as in NAT for HIV, HBV, HCV and HAV, and that contain a<br />maximum of 10.0 IU/&mu;l of Parvovirus B19, are accepted.<br />In addition, Octaplas is produced from plasma pools containing a specified minimum antibody level, which has been shown<br />to have neutralising effect against HAVand Parvovirus B19. Parvovirus B19 infection may be serious for pregnant women<br />(fetal infection) and for individuals with immunodeficiency or increased erythropoiesis (e.g. haemolytic anaemia). HEV may<br />also seriously affect seronegative pregnant women. Therefore Octaplas should only be administered to these patients if<br />strongly indicated.<br />Appropriate vaccination (e.g. against HBV and HAV) should be considered for patients in regular receipt of medicinal<br />products derived from human blood or plasma should be considered.<br />Administration of Octaplas must be based on ABO-blood group specificity. In emergency cases, Octaplas blood group AB<br />can be regarded as universal plasma since it can be given to all patients regardless of blood group.<br />Patients should be observed for at least 20 minutes after the administration.<br />In case of shock or anaphylactic reaction, the infusion must be stopped immediately. The patient should then be treated<br />following the guidelines for shock therapy (see 4.8).<br />It is strongly recommended that every time that Octaplas is administered to a patient, the name and batch number of the<br />product are recorded in order to maintain a link between the patient and the batch of the product.<br />Data on the use of Octaplas in premature children are very limited; therefore, the product should only be administered to<br />these individuals if the benefits clearly outweigh potential risks.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No interactions with other drugs have been identified.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The safety of the use of Octaplas during pregnancy has not been established in controlled clinical trials. It is not known<br />whether Octaplas can affect reproduction capacity. This product should be administered to pregnant or lactating woman<br />only if alternative therapies are regarded inappropriate. For potential risk of parvovirus B19 and HEV transmission, see<br />section 4.4.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After ambulant infusion, the patient should rest for one hour.<br />There are no indications that Octaplas may impair the ability to drive or to operate machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>- Acute mild allergic reaction due to hypersensitivity to infused proteins and characterised by urticaria, fever, chills,<br />nausea, vomiting, and abdominal or back pain may commonly be observed.<br />- Acute and sometimes severe allergic (anaphylactic or anaphylactoid) type of reactions characterised by flushing,<br />hypotension, chest pain, bronchospasms, dyspnoea, and cardio-respiratory collapse may rarely be observed.<br />- High infusion rates may rarely cause cardiovascular effects as a result of citrate toxicity (fall in ionised calcium),<br />especially in patients with liver function disorders. In the course of plasma exchange procedures, symptoms<br />attributable to citrate toxicity such as fatigue, paraesthesia, tremor, and hypocalcemia may be observed rarely.<br />- Administration of Octaplas must be based on ABO-blood group specificity. In case of an incompatible transfusion by<br />mistake, ABO-antibodies in Octaplas will bind to the antigens of recipient red blood cells and cause an immediate or<br />delayed type of haemolytic transfusion reactions.<br />- For safety with respect to transmissible agents, see section 4.4.<br />During clinical trials with Octaplas and its post-approval use, the following adverse reactions have been identified:<br /><strong>Table 1 Adverse reactions that have been identified for Octaplas</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System organ class </strong></p></td><td style="vertical-align:top"><p><strong>Common</strong></p><p><strong>(</strong><strong>&lt;</strong><strong>1% -to &lt; 10%) </strong></p></td><td style="vertical-align:top"><p><strong>Uncommon</strong></p><p><strong>(</strong><strong>&lt;</strong><strong> 0.1% to &lt; 1%)</strong></p></td><td style="vertical-align:top"><p><strong>Rare</strong></p><p><strong>(</strong><strong>&lt;</strong><strong> 0.01% to &lt; 0.1%)</strong></p></td><td style="vertical-align:top"><p><strong>Very Rare</strong></p><p><strong>&lt; 0.01%</strong></p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic</p><p>system</p><p>disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>haemolytic anaemia</p></td></tr><tr><td style="vertical-align:top"><p>Immune system</p><p>disorders</p></td><td style="vertical-align:top"><p>hypersensitivity</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Anaphylactic reaction</p><p>Anaphylactoid</p><p>reaction</p><p>Hypersensitivity</p></td><td style="vertical-align:top"><p>Anaphylactic shock</p></td></tr><tr><td style="vertical-align:top"><p>Metabolic and nutritional</p><p>disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Citrate toxicity</p></td><td style="vertical-align:top"><p>Alkalosis</p></td></tr><tr><td style="vertical-align:top"><p>Psychiatric disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>agitation</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Transfusion-related</p><p>circulatory overload</p><p>Tachycardia</p></td><td style="vertical-align:top"><p>Arrhythmia</p><p>Cardiac arrest</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hypotension</p></td><td style="vertical-align:top"><p>Flushing</p><p>Haemorrhagic</p><p>diathesis</p></td><td style="vertical-align:top"><p>Thromboembolism</p><p>Hypertension</p><p>Circulatory collapse</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and</p><p>mediastinal disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Bronchospasm</p><p>Respiratory disorder</p></td><td style="vertical-align:top"><p>Dyspnoea</p></td><td style="vertical-align:top"><p>Acute pulmonary</p><p>oedema</p><p>Pulmonary</p><p>haemorrhage</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal</p><p>disorders</p></td><td style="vertical-align:top"><p>nausea</p></td><td style="vertical-align:top"><p>Vomiting</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous</p><p>tissue disorders</p></td><td style="vertical-align:top"><p>Rash</p><p>Pruritus</p></td><td style="vertical-align:top"><p>Urticaria</p></td><td style="vertical-align:top"><p>Rash</p><p>Erythematous</p><p>Hyperhidrosis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and</p><p>administration site</p><p>conditions</p></td><td style="vertical-align:top"><p>Chills</p><p>Pyrexia</p></td><td style="vertical-align:top"><p>Localised oedema</p></td><td style="vertical-align:top"><p>Chest pain</p></td><td style="vertical-align:top"><p>Application site</p><p>reaction</p></td></tr><tr><td style="vertical-align:top"><p>Investigations</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Antibody test positive</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Injury, poisoning and</p><p>procedural complications</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Haemolytic</p><p>transfusion</p><p>reaction</p></td></tr></tbody></table><p>&nbsp;</p><p>To report any side effect(s):<br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued<br />monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected<br />adverse reactions.</p><p>The National Pharmacovigilance and Drug Safety Centre (NPC)<br />&bull;&bull; Fax: +966-11-205-7662<br />&bull;&bull; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340<br />&bull;&bull; Toll free phone: 8002490000<br />&bull;&bull; E-mail: npc.drug@sfda.gov.sa<br />&bull;&bull; Website: www.sfda.gov.sa/npc<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>- High dosages or infusion rates may induce hypervolaemia, pulmonary oedema and/or cardiac failure.<br />- High infusion rates may cause cardiovascular effects as a result of citrate toxicity (fall in ionised calcium), especially<br />in patients with liver function disorders.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Plasma substitutes and plasma protein fractions, ATC code: B05A A.<br />The content and distribution of plasma proteins in Octaplas remain in the final product at comparable levels to those in<br />the raw material FFP, i.e. 45-70 mg/mL, and the major plasma proteins are all within the reference ranges for healthy blood<br />donors (see Table 2). Out of a mean total protein content of 52 mg/mL, albumin accounts for 58% (30 mg/mL), whereas<br />the immunoglobulin classes G, A, and M are present at levels of 7.5, 1.6, and 1.0 mg/mL [1], respectively. As a result of<br />the S/D treatment and purification, the content in lipids and lipoproteins is reduced. This is of no relevance within the<br />indications for Octaplas.<br />The manufacturing process levels out inter-donor variations and maintain the plasma proteins in a functional state.<br />Therefore, Octaplas possesses the same clinical activity as the average single-donor FFP unit, but is more standardised. The<br />finished product is tested for coagulation factors V, VIII, and XI, and the inhibitors protein C, protein S, and plasmin inhibitor.<br />A minimum of 0.5 IU/mL is obtained for each of the three coagulation factors, whereas the inhibitor levels are guaranteed<br />equal or higher than 0.7, 0.3, and 0.2 IU/mL. The fibrinogen content is between 1.5 and 4.0 mg/mL. In routine production,<br />all clinically important parameters are within the 2.5-97.5 percentiles reference range for single-donor FFP, except plasmin<br />inhibitor (also known as &alpha;2-antiplasmin) and Protein S &ndash; the latter being just below (see Table 2). Octaplas displays the same<br />von Willebrand factor multimeric pattern as normal plasma.<br />[1] Beeck H, Hellstern P. In vitro characterization of solvent/detergent-treated human plasma and of quarantine fresh frozen<br />plasma. Vox Sang 1998; 74 (Suppl. I):219-223<br /><strong>Table 2: Global coagulation parameters and specific coagulation factors and inhibitors in Octaplas</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Parameter</strong></p></td><td style="vertical-align:top"><p><strong>Octaplas</strong></p><p><strong>Mean &plusmn; standard</strong></p><p><strong>deviation (n = 24)*</strong></p></td><td style="vertical-align:top"><p><strong>Reference range**</strong></p></td></tr><tr><td style="vertical-align:top"><p>Activated partial thromboplastin time [sec]</p></td><td style="vertical-align:top"><p>33 &plusmn; 3</p></td><td style="vertical-align:top"><p>28 - 41</p></td></tr><tr><td style="vertical-align:top"><p>Prothrombin time [sec]</p></td><td style="vertical-align:top"><p>11 &plusmn; &nbsp;0</p></td><td style="vertical-align:top"><p>10 - 14***</p></td></tr><tr><td style="vertical-align:top"><p>Fibrinogen [mg/mL]</p></td><td style="vertical-align:top"><p>2.7&nbsp; &nbsp;&plusmn; &nbsp;0.3</p></td><td style="vertical-align:top"><p>1.5 - 4.0</p></td></tr><tr><td style="vertical-align:top"><p>Coagulation factor II [IU/mL]</p></td><td style="vertical-align:top"><p>0.85 &plusmn; &nbsp;0.04</p></td><td style="vertical-align:top"><p>0.65 - 1.54</p></td></tr><tr><td style="vertical-align:top"><p>Coagulation factor V [IU/mL]</p></td><td style="vertical-align:top"><p>0.95 &nbsp;&plusmn; &nbsp;0.11</p></td><td style="vertical-align:top"><p>0.54 - 1.45</p></td></tr><tr><td style="vertical-align:top"><p>Coagulation factor VII [IU/mL]</p></td><td style="vertical-align:top"><p>1.02 &nbsp;&plusmn; 0.12</p></td><td style="vertical-align:top"><p>0.62 - 1.65</p></td></tr><tr><td style="vertical-align:top"><p>Coagulation factor VIII [IU/mL]</p></td><td style="vertical-align:top"><p>0.78&nbsp; &nbsp;&plusmn; &nbsp;0.14</p></td><td style="vertical-align:top"><p>0.45 - 1.68</p></td></tr><tr><td style="vertical-align:top"><p>Coagulation factor IX [IU/mL]</p></td><td style="vertical-align:top"><p>0.83 &nbsp;&plusmn; &nbsp;&nbsp;0.05</p></td><td style="vertical-align:top"><p>0.45 - 1.48</p></td></tr><tr><td style="vertical-align:top"><p>Coagulation factor X [IU/mL]</p></td><td style="vertical-align:top"><p>0.86&nbsp;&nbsp; &nbsp;&plusmn; &nbsp;0.04</p></td><td style="vertical-align:top"><p>0.68 - 1.48</p></td></tr><tr><td style="vertical-align:top"><p>Coagulation factor XI [IU/mL]</p></td><td style="vertical-align:top"><p>1.07&nbsp; &nbsp;&plusmn; &nbsp;&nbsp;0.13</p></td><td style="vertical-align:top"><p>0.42 - 1.44</p></td></tr><tr><td style="vertical-align:top"><p>Coagulation factor XII [IU/mL]</p></td><td style="vertical-align:top"><p>0.88 &nbsp;&plusmn; &nbsp;&nbsp;0.02</p></td><td style="vertical-align:top"><p>0.40 - 1.52</p></td></tr><tr><td style="vertical-align:top"><p>Coagulation factor XIII [IU/mL]</p></td><td style="vertical-align:top"><p>1.01 &nbsp;&plusmn; &nbsp;&nbsp;0.14</p></td><td style="vertical-align:top"><p>0.65 - 1.65</p></td></tr><tr><td style="vertical-align:top"><p>Von Willebrand factor ristocetin cofactor activity [IU/mL]</p></td><td style="vertical-align:top"><p>0.96 &nbsp;&plusmn; &nbsp;0.20</p></td><td style="vertical-align:top"><p>0.45 - 1.75</p></td></tr><tr><td style="vertical-align:top"><p>ADAMTS13# activity [IU/mL]</p></td><td style="vertical-align:top"><p>0.96&nbsp;&nbsp; &plusmn; &nbsp;0.06</p></td><td style="vertical-align:top"><p>0.50 - 1.10***</p></td></tr><tr><td style="vertical-align:top"><p>Antithrombin [IU/mL]</p></td><td style="vertical-align:top"><p>0.92&nbsp; &nbsp;&plusmn; &nbsp;0.06</p></td><td style="vertical-align:top"><p>0.72 - 1.45</p></td></tr><tr><td style="vertical-align:top"><p>Protein C [IU/mL]</p></td><td style="vertical-align:top"><p>0.90&nbsp;&nbsp; &plusmn; 0.08</p></td><td style="vertical-align:top"><p>0.58 - 1.64</p></td></tr><tr><td style="vertical-align:top"><p>Protein S [IU/mL]</p></td><td style="vertical-align:top"><p>0.50 &nbsp;&plusmn; &nbsp;&nbsp;0.03</p></td><td style="vertical-align:top"><p>0.56 - 1.68</p></td></tr><tr><td style="vertical-align:top"><p>Plasminogen [IU/mL]</p></td><td style="vertical-align:top"><p>0.82 &nbsp;&plusmn; &nbsp;0.08</p></td><td style="vertical-align:top"><p>0.68 - 1.44</p></td></tr><tr><td style="vertical-align:top"><p>Plasmin inhibitor## [IU/mL]</p></td><td style="vertical-align:top"><p>0.32 &nbsp;&plusmn; &nbsp;&nbsp;0.04</p></td><td style="vertical-align:top"><p>0.72 - 1.32</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Octaplas has similar pharmacokinetic properties as FFP.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Virus inactivation is carried out using Tri (N-Butyl) Phosphate (TNBP) and Octoxynol (Triton X-100). These S/D reagents<br />are removed during the purification process. The maximum amounts of TNBP and Octoxynol in the finished product<br />are &lt; 2 &mu;g/mL and &lt; 5 &mu;g/mL, respectively.<br />Pharmacological and toxicological studies in animals indicate that these residual levels should present no clinical problem<br />for the indications and dosages specified.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium citrate dihydrate, Sodium dihydrogen-phosphate, Glycine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>- Octaplas product can be mixed with red blood cells and platelets.<br />- Octaplas must not be mixed with other drugs, as inactivation and precipitation may occur.<br />- To avoid the possibility of clot formation, solutions containing calcium must not be administered by the same<br />intravenous line as Octaplas.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The shelf-life of Octaplas is 4 years when stored at ≤ -18 °C and protected from light.
After thawing Octaplas can be stored for up to 8 hours at +4°C, or 4 hours at room temperature (+20-25°C), before use.
Once the bag has been opened, the product must be used immediately.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The frozen Octaplas product should be stored and transported according to temperature and conditions as mentioned<br />above (see section 6.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Octaplas is filled into sterile, plasticised polyvinyl chloride blood bags which are over-wrapped with a<br />polyamide/polyethylene film.<br />One bag contains 200 mL of Octaplas.<br />OCTAPLAS is supplied in separate presentations according to the following blood groups:<br />Blood group A<br />Blood group B<br />Blood group AB<br />Blood group O</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Octaplas must be transported and stored at a temperature of &le; -18 &deg;C.<br />Do not use after the expiry date given on the label.<br />Thaw in the outer wrapper in a water bath with good circulation at +30 to +37 &deg;C. It is important to prevent water from<br />contaminating the entry port. Temperature in the water bath must never exceed +37 &deg;C and should not be lower than<br />+30 &deg;C.<br />Allow the content of the bag to warm to approximately +37 &deg;C before infusion. The temperature of Octaplas must not<br />exceed +37 &deg;C. The thawing procedure should not take more than 30 minutes.<br />Remove the outer wrapper and examine the bag for cracks or leaks. Avoid shaking.<br />Do not use solutions which are cloudy or have deposits. Thawed Octaplas must not be refrozen. Unused product must be<br />discarded. Any unused product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Octapharma Pharmazeutika
Produktionsges.m.b.H.
Oberlaaer Strasse 235
A-1100 Vienna
Austria
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                10/2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>